News

A panel organized by the FDA cast doubts on the safety of antidepressants during pregnancy — drawing ire from doctors who say ...
Over a whirlwind three weeks, Sarepta Therapeutics has faced tough safety questions around its commercial gene therapy ...
This past year has seen various developments in the field of oncolytic virus therapies - in fundraising and in the clinic.
GSK signed a 12-asset licensing deal with Hengrui Pharma. Generic erosion on Vyvanse continued to hurt Takeda. Celltrion is ...
To treat PTSD, the Department of Veterans Affairs put hundreds of thousands of patients on multiple streams of powerful drugs that put them at risk of suicide.